在面部神经麻中高剂量皮质类固醇治疗:一项回顾性研究
Hiroshi Hyakusoku1, Noriyuki Katsumata1, Meijin Nakayama1
1Otorhinolaryngology, Yokosuka Kyosai Hospital, Yokosuka, JPN.
Cureus
|May 12, 2025
概括
对于贝尔和拉姆齐亨特综合征,降低高剂量皮质类固醇治疗 (HDCT) 与100毫克普雷迪尼索隆 (PSL) 提供与标准200毫克初始剂量相似的治疗疗效. 在HDCT中,较高的PSL初始剂量并不能改善治疗结果.
科学领域:
- 神经学 神经学
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
背景情况:
- 贝尔和拉姆齐·亨特综合征是急性面部神经的常见原因.
- 高剂量皮质类固醇治疗 (HDCT) 与普雷尼索隆 (PSL) 是一种标准的治疗方法,但最佳的初始剂量仍在争论中.
研究的目的:
- 为了比较初始200毫克与100毫克普雷迪尼索隆 (PSL) 剂量的治疗疗效,在高剂量皮质类固醇治疗 (HDCT) 方案中治疗贝尔和Ramsay Hunt综合征.
主要方法:
- 追溯调查259名患者 (172名贝尔,87名兰赛·亨特综合征) 接受标准治疗 (200毫克/天3天) 或减少 (100毫克/天3天) HDCT与PSL和7天的逐渐治疗.
- 患者每月使用Yanagihara面部神经分级系统进行评估,直到康复或六个月.
主要成果:
- 在标准和减少的HDCT之间没有观察到治疗疗效的显著差异.
- 在不到20%的患者中,电子神经图显示标准HDCT没有显著改善.
结论:
- 在HDCT中,初始剂量超过100毫克/天的PSL并没有提高贝尔麻或兰赛亨特综合征的治疗效果.
- 减少100毫克PSL的HDCT治疗方案可能与更高剂量一样有效,可能会最大限度地减少副作用.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
Cushing Syndrome I: Introduction
Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
Cushing Syndrome II: Pathophysiology
Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...


